← Back to Search

Local Anesthetic

PIFB with adjuvants for Pain relief

Phase 4
Waitlist Available
Led By Rawad Hamzi, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 hours after block placement
Awards & highlights

Study Summary

This trial compares post-op pain relief from a nerve block with different solutions. It hypothesizes the best relief comes from the most complex solution.

Eligible Conditions
  • Pain relief
  • Sternotomy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 hours after block placement
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 hours after block placement for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AUC Pain Score
Area Under the Curve (AUC) Pain Score
Secondary outcome measures
Average Cumulative Opioid Consumption
Average Time to Extubation
Average Time to First Opioid Administration
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PIFB with adjuvantsExperimental Treatment1 Intervention
Subjects in this arm receive standard of care PIFB with additional medications after surgery
Group II: Pecto-intercostal Fascial Block (PIFB)Active Control1 Intervention
Subjects in this arm receive standard of care PIFB after surgery
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PIFB with adjuvants
2023
Completed Phase 4
~20

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,247 Previous Clinical Trials
1,005,082 Total Patients Enrolled
Rawad Hamzi, MDPrincipal InvestigatorWake Forest University Health Sciences
1 Previous Clinical Trials
154 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the criteria for potential participants to join this scientific investigation?

"This trial seeks to enroll 20 individuals, aged between 18 and 90 who are suffering from pain. To participate in this study, participants must also be adult patients undergoing a sternotomy cardiac surgery."

Answered by AI

Is the combination of PIFB and adjuvants approved by the Federal Drug Administration?

"Due to the Phase 4 trial status, our team at Power has rated PIFB with adjuvants a 3 on their safety scale. This signifies that this treatment is approved for use in clinical settings."

Answered by AI

Does this trial accept elderly individuals as participants?

"According to the registration requirements, only those aged 18-90 can take part in this study. Subsequently, 80 patients over 65 and 13 under 18 are included in the trial group."

Answered by AI

Are there any available openings in this clinical trial?

"According to the data available on clinicaltrials.gov, this medical study is not presently open for patient recruitment. Initially posted in February 1st 2023 and recently updated in December 22nd 2022, there are 111 alternative trials actively seeking out volunteers at this time."

Answered by AI

What goal is this experimental research seeking to accomplish?

"The goal of this study, which will be assessed during a 6 hour period post-block placement is to assess AUC Pain Score. Secondary metrics include Average Cumulative Opioid Consumption in milligrams; the Average Time to First Opioid Administration taking place after extubation (in minutes); and the Average Time until Extubation (also measured in minutes)."

Answered by AI
~10 spots leftby May 2025